SCHEMBL11727691

SCHEMBL11727691

CCN(CC)CCOc1ccc(-c2oc3ccccc3c2C(=O)c2cc(OC)c(OC)c(OC)c2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.66
▸ BCHE P06276 12/20 0.62
▸ CNR2 P34972 6/20 0.62
▸ ACHE P22303 5/20 0.62
▸ CNR1 P21554 7/20 0.60
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ MLNR O43193 1/20 0.50
▸ CACNA1F O60840 1/20 0.50
▸ PHF2 O75151 1/20 0.50
▸ ABCB11 O95342 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ NR3C1 P04150 1/20 0.50
▸ ERBB2 P04626 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ FYN P06241 1/20 0.50
▸ CHRM2 P08172 1/20 0.50
▸ CHRM4 P08173 1/20 0.50
▸ ABCB1 P08183 1/20 0.50
▸ ADRB1 P08588 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11734542 0.91 APP (0.68) APPBCHECNR2ACHECNR1
SCHEMBL11736445 0.90 APP (0.69) APPBCHECNR2ACHECNR1
SCHEMBL11733902 0.89 L3MBTL1 (0.58) APPBCHECNR2ACHECNR1
SCHEMBL11672968 0.88 APP (0.73) APPBCHECNR2ACHECNR1
SCHEMBL11672632 0.88 APP (0.77) APPBCHECNR2ACHECNR1
SCHEMBL11731490 0.87 APP (0.76) APPBCHECNR2ACHECNR1
SCHEMBL11734682 0.86 APP (0.78) APPBCHECNR2ACHECNR1
SCHEMBL11729870 0.86 APP (0.72) APPBCHECNR2ACHECNR1
SCHEMBL11736401 0.86 APP (0.69) APPBCHECNR2ACHECNR1
SCHEMBL11726989 0.86 APP (0.69) APPBCHECNR2ACHECNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4001426-A HAVING CORONARY VASODILATOR ACTIVITY SMITHKLINE CORPORATION (US) 1977-01-04 — — US disclosed
Send feedback